Latest Market Access News

Page 3 of 38
Carnaby Resources has delivered a robust Pre-Feasibility Study and declared its maiden Ore Reserve at the Greater Duchess Copper Gold Project, setting sights on first production in the second half of 2026.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Sovereign Metals' March 2026 update reveals a robust DFS for its Kasiya Rutile-Graphite Project, a substantial resource upgrade, strategic offtake MOUs, and a high-value heavy rare earth by-product discovery.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Lake Resources made solid progress on the Exploitation Environmental Impact Assessment for its Kachi Lithium Brine Project, targeting approval in Q3 2026, while maintaining strong liquidity and strategic partnerships.
Maxwell Dee
Maxwell Dee
28 Apr 2026
Atomo Diagnostics capitalises on Lumos Diagnostics’ FebriDx FDA CLIA waiver with over $2 million in new sales orders and a $3 million capital raise, expanding its global footprint and product pipeline.
Ada Torres
Ada Torres
28 Apr 2026
Elsight’s Halo connectivity platform has gained critical approval on the U.S. Department of War’s DCMA Blue List, enabling rapid military procurement amid a historic US$75 billion drone budget surge.
Maxwell Dee
Maxwell Dee
28 Apr 2026
Nexsen Limited has cleared a major FDA regulatory hurdle for its StrepSure rapid Group B Streptococcus test, confirmed a clear 510(k) submission pathway, and secured over A$1.7 million in non-dilutive grants to expand clinical validation and market rollout in Asia-Pacific and neonatal diagnostics.
Ada Torres
Ada Torres
28 Apr 2026
OncoSil Medical reported a 60% year-on-year increase in dose sales in Q3 FY26, boosted by expanding treatment centres and advancing clinical trials, while cost-cutting and a new manufacturing facility aim to underpin growth.
Ada Torres
Ada Torres
28 Apr 2026
Proteomics International is pivoting from research to disciplined commercial execution of its proteomics-based diagnostic tests, focusing on distributor partnerships and reimbursement pathways in Australia and the US.
Ada Torres
Ada Torres
28 Apr 2026
Streamplay Studio delivers a fourth consecutive quarter of positive cash flow, underpinned by steady publishing revenues and strategic platform growth in new regions.
Sophie Babbage
Sophie Babbage
28 Apr 2026
Algorae Pharmaceuticals has struck an exclusive commercial and licensing agreement with global pharma Zydus Lifesciences to bring 10 injectable, oral, and specialty medicines to Australia and New Zealand, pending regulatory approvals.
Victor Sage
Victor Sage
28 Apr 2026
Imricor Medical Systems advanced FDA clearances and expanded clinical trials in Q1 CY26, positioning for commercial growth despite higher operating cash outflows.
Ada Torres
Ada Torres
28 Apr 2026
Vitrafy Life Sciences completed Phase II of its U.S. Military platelet cryopreservation study with strong results for a simplified no-wash process, accelerating commercial interest and progressing FDA device registration despite manufacturing delays.
Ada Torres
Ada Torres
28 Apr 2026